Your session is about to expire
← Back to Search
Clinical Decision Support Tool for Migraine (CDST Trial)
N/A
Waitlist Available
Led By Elizabeth Seng, PhD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 of the treatment
Awards & highlights
CDST Trial Summary
This study is evaluating whether a tailored decision support tool may help improve adherence to migraine management strategies.
Eligible Conditions
- Migraine
CDST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 6 of the treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 of the treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence to Acute Migraine Management Strategies: Overuse
Adherence to Acute Migraine Management Strategies: Treat Early
Adherence to Preventive Behavioral Strategies
Secondary outcome measures
Adherence to preventive medication
Average head pain
Headache days
+3 moreCDST Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Clinical Decision Support ToolExperimental Treatment1 Intervention
Tailored education provided via a smartphone application
Group II: Headache EducationActive Control1 Intervention
Non-tailored education provided via a smartphone application.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinical Decision Support Tool
2009
N/A
~1580
Find a Location
Who is running the clinical trial?
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,340 Previous Clinical Trials
649,302 Total Patients Enrolled
7 Trials studying Migraine
1,185 Patients Enrolled for Migraine
Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,857,051 Total Patients Enrolled
4 Trials studying Migraine
300 Patients Enrolled for Migraine
Elizabeth Seng, PhDPrincipal InvestigatorAlbert Einstein College of Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger